UniSuper Management Pty Ltd Boosts Stock Holdings in Danaher Corporation $DHR

UniSuper Management Pty Ltd grew its position in Danaher Corporation (NYSE:DHR) by 10.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 170,291 shares of the conglomerate’s stock after purchasing an additional 16,659 shares during the period. UniSuper Management Pty Ltd’s holdings in Danaher were worth $33,762,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. WFA of San Diego LLC bought a new position in shares of Danaher during the 2nd quarter worth approximately $26,000. Howard Hughes Medical Institute purchased a new stake in shares of Danaher during the second quarter valued at approximately $27,000. TruNorth Capital Management LLC purchased a new stake in shares of Danaher during the third quarter valued at approximately $28,000. Tripletail Wealth Management LLC bought a new stake in Danaher during the third quarter worth $31,000. Finally, Red Tortoise LLC boosted its position in Danaher by 175.0% in the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after purchasing an additional 98 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on DHR shares. Rothschild & Co Redburn reaffirmed a “neutral” rating and set a $220.00 target price (down from $245.00) on shares of Danaher in a research report on Wednesday, October 8th. Barclays raised their price objective on shares of Danaher from $225.00 to $250.00 and gave the stock an “overweight” rating in a report on Wednesday, October 22nd. Leerink Partners boosted their target price on shares of Danaher from $260.00 to $270.00 and gave the company an “outperform” rating in a research note on Friday, January 16th. KeyCorp restated an “overweight” rating on shares of Danaher in a research note on Thursday, December 18th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Danaher in a research note on Monday, December 29th. Twenty equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and a consensus target price of $252.09.

Insider Activity

In other Danaher news, SVP Georgeann Couchara sold 5,174 shares of Danaher stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $210.42, for a total transaction of $1,088,713.08. Following the completion of the transaction, the senior vice president owned 2,625 shares of the company’s stock, valued at $552,352.50. The trade was a 66.34% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Brian W. Ellis sold 21,776 shares of the company’s stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $219.23, for a total value of $4,773,952.48. Following the sale, the senior vice president owned 14,553 shares in the company, valued at approximately $3,190,454.19. This represents a 59.94% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 30,248 shares of company stock worth $6,609,663. 11.10% of the stock is owned by corporate insiders.

Danaher Stock Performance

NYSE DHR opened at $234.91 on Friday. The firm has a market cap of $165.93 billion, a P/E ratio of 48.43, a price-to-earnings-growth ratio of 3.65 and a beta of 0.89. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.33. The company’s 50 day moving average is $230.26 and its 200-day moving average is $213.09. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $258.23.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, October 20th. The conglomerate reported $1.89 earnings per share for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The business had revenue of $6.05 billion during the quarter, compared to analyst estimates of $6 billion. During the same period in the previous year, the business earned $1.71 EPS. Danaher’s revenue was up 4.4% compared to the same quarter last year. Sell-side analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend is Friday, December 26th. Danaher’s dividend payout ratio (DPR) is presently 26.39%.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.